Chemical ID |
Chemical Name |
Interaction |
Interaction Action |
Publication |
---|
C012277 |
1,2-diamino-4-nitrobenzene |
1,2-diamino-4-nitrobenzene results in decreased expression of APOA2 mRNA | decreases expression | 17070881
|
C035314 |
1-nitropropane |
1-nitropropane results in increased expression of APOA2 mRNA | increases expression | 17070881
|
C046728 |
2,2'-azobis(2-amidinopropane) |
2,2'-azobis(2-amidinopropane) results in increased oxidation of APOA2 protein | increases oxidation | 12576517
|
C046728 |
2,2'-azobis(2-amidinopropane) |
[Butylated Hydroxytoluene co-treated with Pentetic Acid] inhibits the reaction [2,2'-azobis(2-amidinopropane) results in increased oxidation of APOA2 protein] | affects cotreatment|decreases reaction|increases oxidation | 12576517
|
C046728 |
2,2'-azobis(2-amidinopropane) |
Butylated Hydroxytoluene inhibits the reaction [2,2'-azobis(2-amidinopropane) results in increased oxidation of APOA2 protein] | decreases reaction|increases oxidation | 12576517
|
C046728 |
2,2'-azobis(2-amidinopropane) |
Pentetic Acid inhibits the reaction [2,2'-azobis(2-amidinopropane) results in increased oxidation of APOA2 protein] | decreases reaction|increases oxidation | 12576517
|
C010914 |
2,4-diaminotoluene |
2,4-diaminotoluene results in decreased expression of APOA2 mRNA | decreases expression | 17070881
|
C025235 |
2,6-diaminotoluene |
2,6-diaminotoluene results in decreased expression of APOA2 mRNA | decreases expression | 17070881
|
C014706 |
2-nitro-4-phenylenediamine |
2-nitro-4-phenylenediamine results in decreased expression of APOA2 mRNA | decreases expression | 17070881
|
C016617 |
2-nitropropane |
2-nitropropane results in decreased expression of APOA2 mRNA | decreases expression | 17070881
|
C028676 |
4-acetylaminofluorene |
4-acetylaminofluorene results in decreased expression of APOA2 mRNA | decreases expression | 17070881
|
D000082 |
Acetaminophen |
Acetaminophen results in decreased expression of APOA2 mRNA | decreases expression | 15120968
|
D016604 |
Aflatoxin B1 |
Aflatoxin B1 affects the expression of APOA2 protein | affects expression | 20106945
|
D000643 |
Ammonium Chloride |
Ammonium Chloride affects the expression of APOA2 mRNA | affects expression | 16483693
|
C095105 |
bexarotene |
bexarotene results in decreased expression of APOA2 mRNA | decreases expression | 16648578
|
D002084 |
Butylated Hydroxytoluene |
[Butylated Hydroxytoluene co-treated with Pentetic Acid] inhibits the reaction [2,2'-azobis(2-amidinopropane) results in increased oxidation of APOA2 protein] | affects cotreatment|decreases reaction|increases oxidation | 12576517
|
D002084 |
Butylated Hydroxytoluene |
Butylated Hydroxytoluene inhibits the reaction [2,2'-azobis(2-amidinopropane) results in increased oxidation of APOA2 protein] | decreases reaction|increases oxidation | 12576517
|
D002251 |
Carbon Tetrachloride |
Carbon Tetrachloride results in increased expression of APOA2 mRNA | increases expression | 11566570
|
D002995 |
Clofibric Acid |
Clofibric Acid affects the expression of APOA2 mRNA | affects expression | 17602206
|
D016572 |
Cyclosporine |
Cyclosporine results in decreased expression of APOA2 mRNA | decreases expression | 20106945
|
D004052 |
Diethylnitrosamine |
Diethylnitrosamine results in decreased expression of APOA2 mRNA | decreases expression | 19638242
|
D015073 |
2-Acetylaminofluorene |
2-Acetylaminofluorene results in decreased expression of APOA2 mRNA | decreases expression | 17070881
|
C039281 |
furan |
furan results in decreased expression of APOA2 mRNA | decreases expression | 15120968
|
C029424 |
hydrazine |
hydrazine results in decreased expression of APOA2 mRNA | decreases expression | 15370871
|
D004369 |
Pentetic Acid |
[Butylated Hydroxytoluene co-treated with Pentetic Acid] inhibits the reaction [2,2'-azobis(2-amidinopropane) results in increased oxidation of APOA2 protein] | affects cotreatment|decreases reaction|increases oxidation | 12576517
|
D004369 |
Pentetic Acid |
Pentetic Acid inhibits the reaction [2,2'-azobis(2-amidinopropane) results in increased oxidation of APOA2 protein] | decreases reaction|increases oxidation | 12576517
|
C006253 |
pirinixic acid |
[pirinixic acid binds to and results in increased activity of PPARA protein] which results in increased expression of APOA2 mRNA | affects binding|increases activity|increases expression | 19710929
|
C006253 |
pirinixic acid |
pirinixic acid results in increased expression of APOA2 mRNA | increases expression | 17426115
|
C017947 |
sodium arsenite |
sodium arsenite affects the expression of APOA2 mRNA | affects expression | 17450228
|
Disease ID |
Disease Name |
Direct Evidence |
Inference Chemical Name |
Inference Score |
Publication |
---|
MESH:D000138 |
Acidosis |
|
Ammonium Chloride |
3.41 | 18287403 |
MESH:D055371 |
Acute Lung Injury |
|
pirinixic acid |
2.97 | 18653653 |
MESH:D000236 |
Adenoma |
|
2-Acetylaminofluorene |
6.74 | 10737359 |
MESH:D000236 |
Adenoma |
|
Diethylnitrosamine |
6.74 | 6695378 10737359 |
MESH:D002759 |
Adenoma, Bile Duct |
|
2-Acetylaminofluorene |
5.86 | 6705139 |
MESH:D018248 |
Adenoma, Liver Cell |
|
Diethylnitrosamine |
9.59 | 19052882 17620307 19061943 17162532 16434500 18056438 |
MESH:D018248 |
Adenoma, Liver Cell |
|
pirinixic acid |
9.59 | 16434500 |
MESH:D000310 |
Adrenal Gland Neoplasms |
|
sodium arsenite |
4.55 | 15276417 |
MESH:D018246 |
Adrenocortical Adenoma |
|
sodium arsenite |
4.75 | 17306315 16712894 |
MESH:D000799 |
Angioedema |
|
Acetaminophen |
3.69 | 10982225 |
MESH:D001321 |
Autistic Disorder |
|
Acetaminophen |
1.43 | 18445737 |
MESH:D001778 |
Blood Coagulation Disorders |
|
pirinixic acid |
3.01 | 19483382 |
MESH:D001943 |
Breast Neoplasms |
|
2,4-diaminotoluene |
2.13 | 11921183 |
MESH:D001943 |
Breast Neoplasms |
|
bexarotene |
2.13 | 16344269 16818667 |
MESH:D001943 |
Breast Neoplasms |
|
Diethylnitrosamine |
2.13 | 17474063 |
MESH:D002252 |
Carbon Tetrachloride Poisoning |
|
Carbon Tetrachloride |
3.63 | 18705752 16097048 10355542 16124888 16050911 16011737 16192424 3786805 15673190 16227642 15700767 15721981 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
2-Acetylaminofluorene |
11.07 | 17761372 10737359 3084413 6705139 3581430 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Acetaminophen |
11.07 | 3084413 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Aflatoxin B1 |
11.07 | 21507988 12619106 12907637 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Carbon Tetrachloride |
11.07 | 18788625 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Diethylnitrosamine |
11.07 | 19539802 19335982 17978847 11831363 16328049 18785209 18506893 19052882 16502159 16807293 20727157 20101231 19701751 16681979 18788625 3084413 19919837 20084675 18210153 20007298 16878318 18393292 20514400 19519916 17173139 20935162 16288022 18056438 19171122 19822196 17138121 17162532 18971187 18494052 10672840 17761372 16830150 19383236 20512989 16779866 18978308 19107877 19418558 18691550 19208518 19394651 18665156 17428255 17055752 20432363 16698587 21159647 16540662 3581430 20214788 20524982 16569478 10737359 16935385 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
sodium arsenite |
11.07 | 15276417 17306315 16507464 |
MESH:D002289 |
Carcinoma, Non-Small-Cell Lung |
|
bexarotene |
3.18 | 16247446 |
MESH:D002294 |
Carcinoma, Squamous Cell |
|
sodium arsenite |
2.34 | 18572023 |
MESH:D002386 |
Cataract |
|
Acetaminophen |
2.49 | 10977129 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
Cyclosporine |
10.58 | 12371664 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
Diethylnitrosamine |
10.58 | 7505956 21159647 17174075 2727394 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
sodium arsenite |
10.58 | 20056578 19524636 |
MESH:D018281 |
Cholangiocarcinoma |
|
Diethylnitrosamine |
3.56 | 19052882 |
MESH:D002779 |
Cholestasis |
|
Cyclosporine |
7.39 | 19486331 |
MESH:D002779 |
Cholestasis |
|
pirinixic acid |
7.39 | 19176532 |
MESH:D003876 |
Dermatitis, Atopic |
|
pirinixic acid |
2.36 | 18249437 |
MESH:D003924 |
Diabetes Mellitus, Type 2 |
|
Diethylnitrosamine |
2.16 | 20387270 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
2-nitropropane |
8.68 | 15804453 16445897 20517888 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Acetaminophen |
8.68 | 19164858 16781746 15619225 19370779 19923254 12705907 2444490 16177239 14550746 16227642 11739529 16109766 11743745 16081117 19420014 12958197 11529661 16393943 12540782 12392966 12594235 15968718 11287661 17522070 18713872 14725611 10663392 10774834 19416960 16485898 19739265 11834606 11461765 11421492 18071297 17562736 12153990 14986274 10915739 19085960 17906064 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Carbon Tetrachloride |
8.68 | 10915739 17522070 2869522 16227642 16177239 7440962 19085960 15998439 21278145 6623471 15968718 11566570 6884620 4309450 3786805 9327722 10092053 7120509 15027814 7179309 19336974 3732212 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Diethylnitrosamine |
8.68 | 19107877 |
MESH:D056487 |
Drug-Induced Liver Injury, Chronic |
|
Acetaminophen |
3.95 | 19426721 |
MESH:D050171 |
Dyslipidemias |
marker/mechanism |
|
| |
MESH:D004487 |
Edema |
|
pirinixic acid |
2.35 | 12083418 |
MESH:D004931 |
Esophageal Achalasia |
|
Diethylnitrosamine |
4.97 | 16302075 |
MESH:D005234 |
Fatty Liver |
|
Carbon Tetrachloride |
17.61 | 17595544 15959796 19224547 16045604 16239168 12631006 61145 12795759 |
MESH:D005234 |
Fatty Liver |
|
Cyclosporine |
17.61 | 19224547 |
MESH:D005234 |
Fatty Liver |
|
Diethylnitrosamine |
17.61 | 20387270 21071580 |
MESH:D005234 |
Fatty Liver |
|
pirinixic acid |
17.61 | 20131406 19236843 |
MESH:D005355 |
Fibrosis |
|
Carbon Tetrachloride |
8.17 | 18705752 |
MESH:D005355 |
Fibrosis |
|
Cyclosporine |
8.17 | 12168785 12639820 |
MESH:D005756 |
Gastritis |
|
Acetaminophen |
3.52 | 16983495 |
MESH:D005833 |
Genital Neoplasms, Female |
|
sodium arsenite |
4.53 | 16452187 |
MESH:D005885 |
Gingival Hyperplasia |
|
Cyclosporine |
4.07 | 8708960 |
MESH:D006333 |
Heart Failure |
|
pirinixic acid |
2.44 | 20558911 |
MESH:D006390 |
Hemangioendothelioma |
|
2-Acetylaminofluorene |
5.16 | 6705139 |
MESH:D006394 |
Hemangiosarcoma |
|
2-Acetylaminofluorene |
4.27 | 6705139 |
MESH:D006457 |
Hemoglobinuria, Paroxysmal |
|
Cyclosporine |
4.27 | 15720958 |
MESH:D006505 |
Hepatitis |
|
Carbon Tetrachloride |
3.45 | 19900420 19110552 |
MESH:D006529 |
Hepatomegaly |
|
pirinixic acid |
2.85 | 16221962 19772884 19176532 18467677 |
MESH:D006689 |
Hodgkin Disease |
|
sodium arsenite |
3.03 | 12676792 |
MESH:D006930 |
Hyperalgesia |
|
Acetaminophen |
2.58 | 16870215 |
MESH:D006932 |
Hyperbilirubinemia |
|
Carbon Tetrachloride |
4.38 | 16899240 |
OMIM:143890 |
HYPERCHOLESTEROLEMIA, AUTOSOMAL DOMINANT |
marker/mechanism |
|
| |
MESH:D006943 |
Hyperglycemia |
|
pirinixic acid |
3.05 | 20558911 |
MESH:D006967 |
Hypersensitivity |
|
Butylated Hydroxytoluene |
4.37 | 17604070 |
MESH:D006973 |
Hypertension |
|
Cyclosporine |
2.04 | 10903974 |
MESH:D006975 |
Hypertension, Portal |
|
Carbon Tetrachloride |
3.94 | 15338365 |
MESH:D007248 |
Infertility, Male |
|
sodium arsenite |
2.89 | 15346721 12646999 |
MESH:D007249 |
Inflammation |
|
Diethylnitrosamine |
2.30 | 18785209 |
MESH:D007333 |
Insulin Resistance |
|
pirinixic acid |
2.53 | 16306350 |
MESH:D007638 |
Keratoconjunctivitis Sicca |
|
Cyclosporine |
4.29 | 15604871 |
MESH:D007674 |
Kidney Diseases |
|
Acetaminophen |
9.50 | 15629191 12587719 |
MESH:D007674 |
Kidney Diseases |
|
Cyclosporine |
9.50 | 8314463 10903974 18776723 |
MESH:D007674 |
Kidney Diseases |
|
sodium arsenite |
9.50 | 20008137 |
MESH:D007680 |
Kidney Neoplasms |
|
Cyclosporine |
2.61 | 12371664 |
MESH:D008103 |
Liver Cirrhosis |
|
Carbon Tetrachloride |
6.33 | 16239168 16943688 11408273 17157831 21278145 11903743 17334410 17174718 16221502 |
MESH:D008103 |
Liver Cirrhosis |
|
Diethylnitrosamine |
6.33 | 20032147 18407596 19638242 18522880 18665156 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Carbon Tetrachloride |
2.27 | 18412020 16015684 15338365 14716833 16136751 15650968 17922224 17976157 17714472 17721639 16638106 15925388 16248980 14512876 18210741 18395095 15931870 16033810 12546737 15959796 18251166 17565644 18395914 11481614 18277467 20821823 18472094 12609069 17557913 14716496 12649538 12666154 18376398 17900296 12898905 18166357 18472332 15893842 17869086 12389079 15818738 10355542 17481882 13678700 14748882 16011737 18429990 18054572 12958196 16116963 17766677 18420326 12632514 18317297 17631135 18705752 12741479 18263696 18339082 17698563 12586293 17944888 15996030 17823541 12445421 14724832 17525996 15052691 16192424 14620537 12632512 18481824 17708605 15057751 15673190 15370692 18156304 18006644 17805973 18205269 15362042 16027843 18187930 12445418 17640975 18279442 18418968 16097048 15730626 17761835 15123356 12667390 15876570 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
pirinixic acid |
2.27 | 15474484 |
MESH:D008107 |
Liver Diseases |
|
Acetaminophen |
6.24 | 16610002 12969438 19784758 19460945 19014921 11587558 16611625 12587719 |
MESH:D008107 |
Liver Diseases |
|
Carbon Tetrachloride |
6.24 | 15720792 17285989 15830285 16964402 16246199 |
MESH:D008107 |
Liver Diseases |
|
Diethylnitrosamine |
6.24 | 17034775 |
MESH:D017093 |
Liver Failure |
|
Carbon Tetrachloride |
4.01 | 15123358 |
MESH:D017114 |
Liver Failure, Acute |
|
Acetaminophen |
8.96 | 17185352 16871587 |
MESH:D017114 |
Liver Failure, Acute |
|
Carbon Tetrachloride |
8.96 | 16899240 14706259 |
MESH:D008113 |
Liver Neoplasms |
|
2-Acetylaminofluorene |
24.98 | 10737359 11376686 18001218 16273603 14678523 10672840 |
MESH:D008113 |
Liver Neoplasms |
|
Aflatoxin B1 |
24.98 | 2125692 15890375 9163691 18177683 |
MESH:D008113 |
Liver Neoplasms |
|
Butylated Hydroxytoluene |
24.98 | 18177683 |
MESH:D008113 |
Liver Neoplasms |
|
Carbon Tetrachloride |
24.98 | 19294768 |
MESH:D008113 |
Liver Neoplasms |
|
Clofibric Acid |
24.98 | 17602206 |
MESH:D008113 |
Liver Neoplasms |
|
Diethylnitrosamine |
24.98 | 19294768 9163691 21278145 19256749 19426721 19833225 19499222 18644402 19638242 18978307 20137499 20492335 12771043 20452335 19690152 19427195 12112319 21047994 18977376 18754104 19090486 10737359 19551842 20501860 19255062 15885732 18648771 20118626 20101389 20405173 19850985 16942905 2862719 19812893 20434301 19073162 19254457 21167192 2422723 19642983 19996281 20583210 21071580 15175105 |
MESH:D008113 |
Liver Neoplasms |
|
pirinixic acid |
24.98 | 20007298 16377806 15890375 |
MESH:D008113 |
Liver Neoplasms |
|
sodium arsenite |
24.98 | 16712894 15276417 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
2-Acetylaminofluorene |
13.41 | 1399818 534488 6150874 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
Aflatoxin B1 |
13.41 | 8603461 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
Carbon Tetrachloride |
13.41 | 15583823 12014681 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
Diethylnitrosamine |
13.41 | 2563599 18544905 18308698 17174075 17854601 18253720 18282651 18775883 16842330 19126423 19519916 21159647 9362446 18164116 19009564 19004024 16267830 18093689 19539802 3124819 18079962 17942915 |
MESH:D008171 |
Lung Diseases |
|
sodium arsenite |
3.07 | 19095001 |
MESH:D008175 |
Lung Neoplasms |
|
2-Acetylaminofluorene |
8.33 | 11376686 |
MESH:D008175 |
Lung Neoplasms |
|
Aflatoxin B1 |
8.33 | 14755239 |
MESH:D008175 |
Lung Neoplasms |
|
bexarotene |
8.33 | 17849452 |
MESH:D008175 |
Lung Neoplasms |
|
Butylated Hydroxytoluene |
8.33 | 19359593 18597497 11696405 15390079 11246140 19925653 16337739 |
MESH:D008175 |
Lung Neoplasms |
|
Diethylnitrosamine |
8.33 | 20970405 6695378 21163286 20512841 |
MESH:D008175 |
Lung Neoplasms |
|
sodium arsenite |
8.33 | 15276417 17077188 19931552 17306315 16712894 |
MESH:D016410 |
Lymphoma, T-Cell, Cutaneous |
|
bexarotene |
5.00 | 11161223 |
MESH:D008325 |
Mammary Neoplasms, Experimental |
|
2,4-diaminotoluene |
9.77 | 11921183 |
MESH:D008325 |
Mammary Neoplasms, Experimental |
|
bexarotene |
9.77 | 15591091 19196723 19196722 |
MESH:D008325 |
Mammary Neoplasms, Experimental |
|
Butylated Hydroxytoluene |
9.77 | 1500032 |
MESH:D008545 |
Melanoma |
|
sodium arsenite |
2.01 | 16487513 19082730 |
MESH:D008546 |
Melanoma, Experimental |
|
Acetaminophen |
3.42 | 19513568 |
MESH:D008664 |
Metal Metabolism, Inborn Errors |
|
Cyclosporine |
4.64 | 16801185 |
MESH:D009135 |
Muscular Diseases |
|
pirinixic acid |
3.36 | 16239165 |
MESH:D009203 |
Myocardial Infarction |
|
pirinixic acid |
2.08 | 19151258 |
MESH:D015428 |
Myocardial Reperfusion Injury |
|
pirinixic acid |
2.83 | 16411023 |
MESH:D009336 |
Necrosis |
|
2-nitropropane |
5.41 | 12195237 |
MESH:D009362 |
Neoplasm Metastasis |
|
Diethylnitrosamine |
2.51 | 9029167 3581430 |
MESH:D009369 |
Neoplasms |
|
pirinixic acid |
4.70 | 17405874 |
MESH:D009369 |
Neoplasms |
|
sodium arsenite |
4.70 | 11559025 |
MESH:D009374 |
Neoplasms, Experimental |
|
sodium arsenite |
3.52 | 20056578 |
MESH:D009376 |
Neoplasms, Hormone-Dependent |
|
bexarotene |
4.63 | 19196722 |
MESH:D009402 |
Nephrosis, Lipoid |
|
Cyclosporine |
4.29 | 17954296 |
MESH:D009404 |
Nephrotic Syndrome |
|
Cyclosporine |
3.15 | 19348381 18481113 |
MESH:D009436 |
Neural Tube Defects |
|
sodium arsenite |
3.05 | 12854658 |
MESH:D019636 |
Neurodegenerative Diseases |
|
Acetaminophen |
7.77 | 18514411 |
MESH:D019636 |
Neurodegenerative Diseases |
|
Diethylnitrosamine |
7.77 | 20387270 |
MESH:D009461 |
Neurologic Manifestations |
|
Diethylnitrosamine |
4.97 | 20387270 |
MESH:D009765 |
Obesity |
|
pirinixic acid |
1.78 | 20558911 |
MESH:D010051 |
Ovarian Neoplasms |
|
sodium arsenite |
2.39 | 15276417 17306315 |
MESH:D010146 |
Pain |
|
Acetaminophen |
2.27 | 16870215 |
MESH:D010190 |
Pancreatic Neoplasms |
|
Diethylnitrosamine |
2.37 | 16540662 |
MESH:D011014 |
Pneumonia |
|
Butylated Hydroxytoluene |
5.01 | 11893704 |
MESH:D011230 |
Precancerous Conditions |
|
Cyclosporine |
8.51 | 12371664 |
MESH:D011230 |
Precancerous Conditions |
|
Diethylnitrosamine |
8.51 | 2563599 |
MESH:D011471 |
Prostatic Neoplasms |
|
sodium arsenite |
3.34 | 16039940 |
MESH:D011565 |
Psoriasis |
|
Cyclosporine |
2.18 | 16882103 |
MESH:D015427 |
Reperfusion Injury |
|
pirinixic acid |
2.31 | 19058328 |
MESH:D012878 |
Skin Neoplasms |
|
sodium arsenite |
2.63 | 19524636 18572023 |
MESH:D016135 |
Spinal Dysraphism |
|
sodium arsenite |
3.68 | 12854658 |
MESH:D013274 |
Stomach Neoplasms |
|
Diethylnitrosamine |
1.75 | 18456281 |
MESH:D013964 |
Thyroid Neoplasms |
|
Diethylnitrosamine |
2.87 | 7505956 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
2-Acetylaminofluorene |
5.26 | 15289314 15867355 1399818 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
sodium arsenite |
5.26 | 11723127 16452187 16712894 17306315 |
MESH:D014581 |
Urticaria |
|
Acetaminophen |
2.83 | 10982225 |
MESH:D002583 |
Uterine Cervical Neoplasms |
|
sodium arsenite |
3.63 | 11813266 |
MESH:D014605 |
Uveitis |
|
Cyclosporine |
3.83 | 1336536 |
MESH:D014652 |
Vascular Diseases |
|
sodium arsenite |
4.27 | 17056641 |
MESH:D014985 |
Xerophthalmia |
|
Cyclosporine |
4.29 | 17120751 |